282 related articles for article (PubMed ID: 37240007)
1. Boosting the Antibacterial Activity of Azithromycin on Multidrug-Resistant
Al-Marzooq F; Ghazawi A; Daoud L; Tariq S
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240007
[TBL] [Abstract][Full Text] [Related]
2. Importance of Real-Time Assays To Distinguish Multidrug Efflux Pump-Inhibiting and Outer Membrane-Destabilizing Activities in Escherichia coli.
Misra R; Morrison KD; Cho HJ; Khuu T
J Bacteriol; 2015 Aug; 197(15):2479-88. PubMed ID: 25962916
[TBL] [Abstract][Full Text] [Related]
3. Random mutagenesis of the multidrug transporter AcrB from Escherichia coli for identification of putative target residues of efflux pump inhibitors.
Schuster S; Kohler S; Buck A; Dambacher C; König A; Bohnert JA; Kern WV
Antimicrob Agents Chemother; 2014 Nov; 58(11):6870-8. PubMed ID: 25182653
[TBL] [Abstract][Full Text] [Related]
4. Discerning the role of polymyxin B nonapeptide in restoring the antibacterial activity of azithromycin against antibiotic-resistant
Al-Marzooq F; Ghazawi A; Tariq S; Daoud L; Collyns T
Front Microbiol; 2022; 13():998671. PubMed ID: 36212888
[TBL] [Abstract][Full Text] [Related]
5. The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PAβN) permeabilizes the outer membrane of gram-negative bacteria.
Lamers RP; Cavallari JF; Burrows LL
PLoS One; 2013; 8(3):e60666. PubMed ID: 23544160
[TBL] [Abstract][Full Text] [Related]
6. Aminoacyl β-naphthylamides as substrates and modulators of AcrB multidrug efflux pump.
Kinana AD; Vargiu AV; May T; Nikaido H
Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1405-10. PubMed ID: 26787896
[TBL] [Abstract][Full Text] [Related]
7. The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coli.
Chollet R; Chevalier J; Bryskier A; Pagès JM
Antimicrob Agents Chemother; 2004 Sep; 48(9):3621-4. PubMed ID: 15328143
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of outer membrane porin gene
Luo X-W; Li P-L; Zhai Y-J; Pan Y-S; Hu G-Z; He D-D
Microbiol Spectr; 2024 Apr; 12(4):e0391823. PubMed ID: 38441474
[TBL] [Abstract][Full Text] [Related]
9. Absence, loss-of-function, or inhibition of Escherichia coli AcrB does not increase expression of other efflux pump genes supporting the discovery of AcrB inhibitors as antibiotic adjuvants.
Ciusa ML; Marshall RL; Ricci V; Stone JW; Piddock LJV
J Antimicrob Chemother; 2022 Feb; 77(3):633-640. PubMed ID: 34897478
[TBL] [Abstract][Full Text] [Related]
10. Synergistic Actions of Benzyl Isothiocyanate with Ethylenediaminetetraacetic Acid and Efflux Pump Inhibitor Phenylalanine-Arginine β-Naphthylamide Against Multidrug-Resistant
Lin KH; Lo CC; Chou MC; Yeh TH; Chen KL; Liao WY; Lo HR
Microb Drug Resist; 2020 May; 26(5):468-474. PubMed ID: 31755808
[TBL] [Abstract][Full Text] [Related]
11. Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF).
Bohnert JA; Schuster S; Fähnrich E; Trittler R; Kern WV
J Antimicrob Chemother; 2007 Jun; 59(6):1216-22. PubMed ID: 17062614
[TBL] [Abstract][Full Text] [Related]
12. Metabolomics Reveal Potential Natural Substrates of AcrB in Escherichia coli and Salmonella enterica Serovar Typhimurium.
Wang-Kan X; Rodríguez-Blanco G; Southam AD; Winder CL; Dunn WB; Ivens A; Piddock LJV
mBio; 2021 Mar; 12(2):. PubMed ID: 33785633
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coli.
Opperman TJ; Kwasny SM; Kim HS; Nguyen ST; Houseweart C; D'Souza S; Walker GC; Peet NP; Nikaido H; Bowlin TL
Antimicrob Agents Chemother; 2014; 58(2):722-33. PubMed ID: 24247144
[TBL] [Abstract][Full Text] [Related]
14. Total alkaloids of Sophorea alopecuroides-induced down-regulation of AcrAB-TolC efflux pump reverses susceptibility to ciprofloxacin in clinical multidrug resistant Escherichia coli isolates.
Zhou X; Jia F; Liu X; Wang Y
Phytother Res; 2012 Nov; 26(11):1637-43. PubMed ID: 22371352
[TBL] [Abstract][Full Text] [Related]
15. Restoring colistin sensitivity in colistin-resistant
Cui X-d; Liu X-k; Ma X-y; Li S-h; Zhang J-k; Han R-j; Yi K-f; Liu J-h; Pan Y-s; He D-d; Hu G-z; Zhai Y-j
mSphere; 2024 Jun; 9(6):e0018224. PubMed ID: 38738873
[TBL] [Abstract][Full Text] [Related]
16. An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG).
Kanagaratnam R; Sheikh R; Alharbi F; Kwon DH
Phytomedicine; 2017 Dec; 36():194-200. PubMed ID: 29157815
[TBL] [Abstract][Full Text] [Related]
17. Kinetic analysis of the inhibition of the drug efflux protein AcrB using surface plasmon resonance.
Mowla R; Wang Y; Ma S; Venter H
Biochim Biophys Acta Biomembr; 2018 Apr; 1860(4):878-886. PubMed ID: 28890187
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Efflux Pump Inhibitors on the Activity of Selected Non-Antibiotic Medicinal Products against Gram-Negative Bacteria.
Laudy AE; Kulińska E; Tyski S
Molecules; 2017 Jan; 22(1):. PubMed ID: 28085074
[TBL] [Abstract][Full Text] [Related]
19. A phenylalanine-arginine beta-naphthylamide sensitive multidrug efflux pump involved in intrinsic and acquired resistance of Campylobacter to macrolides.
Mamelli L; Amoros JP; Pagès JM; Bolla JM
Int J Antimicrob Agents; 2003 Sep; 22(3):237-41. PubMed ID: 13678827
[TBL] [Abstract][Full Text] [Related]
20. The efflux pump inhibitor phenylalanine-arginine β-naphthylamide (PAβN) increases resistance to carbapenems in Chilean clinical isolates of KPC-producing Klebsiella pneumoniae.
Vera-Leiva A; Carrasco-Anabalón S; Lima CA; Villagra N; Domínguez M; Bello-Toledo H; González-Rocha G
J Glob Antimicrob Resist; 2018 Mar; 12():73-76. PubMed ID: 29275225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
